Dynavax – Talk Bio

Actionable Insights Powered by AI

Dynavax Highlights Comparable Efficacy and Improved Tolerability of Z-1018 Shingles Vaccine vs. Shingrix

3 weeks ago talkbio0Tagged aspects of adverse effects, Dynavax, Effectiveness, Herpes zoster disease, Immunogenicity (package insert), Shingrix, Vaccines, Z-1018

Dynavax; Z-1018; shingles vaccine; Shingrix; vaccine efficacy; side effects; Phase 1/2 trial; immunogenicity

FDA Rejects Dynavax’s Heplisav-B Expansion Due to Data Gaps

1 year ago talkbio0Tagged Dynavax, expansion, Hepatitis B, Heplisav-B, Rejection (Psychology), United States Food and Drug Administration, Vaccines

FDA, Dynavax, Heplisav-B, data gaps, rejection, expansion, vaccine, hepatitis B